Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients

Shuoer Wang; Yidi Sun; Songjiao Zhao; Feng Wei; Gong Yang

doi:10.3934/mbe.2020005

Mathematical Biosciences and Engineering (Jan 2020)

Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients

Shuoer Wang,
Yidi Sun,
Songjiao Zhao,
Feng Wei,
Gong Yang

Affiliations

Shuoer Wang: 1. Central Laboratory, The Fifth People's Hospital of Shanghai Fudan University, Shanghai 200000, China 2. Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200000, China 3. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200000, China
Yidi Sun: 4. Key Lab of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200000, China
Songjiao Zhao: 5. Eye and ENT Hospital of Fudan University, Shanghai 200000, China
Feng Wei: 6. Department of Gastroenterology, The Fifth People's Hospital of Shanghai Fudan University, Shanghai 200000, China
Gong Yang: 1. Central Laboratory, The Fifth People's Hospital of Shanghai Fudan University, Shanghai 200000, China 2. Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200000, China 3. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200000, China

DOI: https://doi.org/10.3934/mbe.2020005
Journal volume & issue: Vol. 17, no. 1
pp. 92 – 104

Abstract

Read online

BackgroundTriple-negative breast cancer (TNBC) is a subtype of breast cancer with stronger invasive capacity. For the operation strategies of early staged (stage Ⅰ and stage Ⅱ) TNBC patients, BCS plus radiotherapy (BCS+RT), mastectomy only (MRM only) or MRM plus radiotherapy (MRM+RT) is feasible, but no clear conclusion has been made on the choice of these treatments. MethodsThe early staged TNBC patients (stage Ⅰ and stage Ⅱ) from the Surveillance, Epidemiology and End Results (SEER) program database between 1973 and 2014 were included in the study. Survival curves, univariate and multivariate cox proportional hazards models and propensity score weighting were applied to evaluate the prognostic impact among BCS+RT, MRM only and MRM+RT for patients. ResultsBoth overall and cancer-specific survival analysis showed that BCS+RT had better prognostic effect than MRM and MRM+RT in the cohort of early-staged triple-negative breast cancer patients (overall survival, P < 0.001; cancer-specific survival, P < 0.001). By taking all the risk factors into a multivariate cox proportional model, MRM and MRM+RT remained to have detrimental effect on the prognosis compared with BCS+RT as shown by either overall (HR = 1.742, CI = 1.387-2.188, P < 0.001; HR = 1.449, CI = 1.038-2.204, P = 0.029) or cancer-specific survival (HR = 1.876, CI = 1.415-2.489, P < 0.001; HR = 1.701, CI = 1.168-2.478, P = 0.006). After we performed propensity score weighting and integrated the weights for each covariate in the multivariate cox proportional model. BCS+RT remained to be prognostic beneficial compared to the other treatment options (P < 0.001). ConclusionBCS+RT demonstrated better prognosis than MRM only and MRM+RT treatments for early-staged TNBC patients.

Published in Mathematical Biosciences and Engineering

ISSN: 1551-0018 (Online)
Publisher: AIMS Press
Country of publisher: United States
LCC subjects: Technology: Chemical technology: Biotechnology; Science: Mathematics
Website: https://www.aimspress.com/journal/MBE

About the journal

Abstract

Keywords